Log in with your email address username.


[Correspondence] Oseltamivir for influenza – Authors’ reply

We thank the correspondents for their interest in our study.1 We did our meta-analysis of oseltamivir treatment studies in view of the controversy that has arisen about oseltamivir’s rational use. To us, an analysis with the most robust design, namely an individual patient data analysis, would help clarify issues of importance not only to clinicians but also to public health decision makers. We generally agree with Peter Doshi and colleagues who concluded that the overall results were not strikingly different from their meta-analysis, which used data obtained from study reports alone.